EPIGEN BIOSCIENCES INC
SAN DIEGO, United States · Founded 2015 · $54.2M raised
- Headquarters
- SAN DIEGO, California
- Employees
- 1–10
- Founded
- 2015
- Business Model
- B2B
- Website
- epigenbiosciences.com
- Total Funding
- $54.2M
- Last Round
- $1.2M GrantAug 2019
About
Epigen Biosciences is a San Diego, California-based pharmaceutical company specializing in small-molecule drug discovery to address unmet medical needs. The company develops innovative, proprietary drug candidates through a translational approach that bridges laboratory breakthroughs to clinical applications via collaborations with leading academic groups. Epigen's pipeline targets multiple therapeutic areas including diabetic kidney disease, Alzheimer's disease and ALS, Fragile X Syndrome, and stroke and traumatic brain injury. In May 2018, Epigen entered a collaboration with Novo Nordisk to license its LPA1 receptor program for up to $200 million.
Summary
EPIGEN BIOSCIENCES INC is a Biotech company based in SAN DIEGO, United States, founded in 2015. It has raised $54.2M in total, most recently a $1.2M Grant round in Aug 2019.
Tech & App Stack
3 technologies & apps tracked
Create a free account — 25 credits a month to unlock the full tech & app stack, funding history, and valuations.
Funding History
No funding data available yet.
Know something? Help us improve our data.
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...

Global fertility clinics platform

Specialty pharmaceutical company
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.